William Kerr

William Kerr

Company: Alterna Therapeutics

Job title: Chief Scientific Officer

Seminars:

Live Q&A – Ask the Speakers Your Burning Questions 12:20 pm

Read more

day: Day One

Advancing SHIP Inhibitors as Potential Therapeutics 12:00 pm

 Modulating the activity of the Src Homology 2 (SH2)-containing Inositol 5 0-Phosphatase (SHIP) enzyme family with small molecule inhibitors provides a useful and unconventional method of influencing cell signaling in the PI3K pathway This presentation will discuss research that support targeting the SHIP1, SHIP2 or both enzymes for therapeutic purposesRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.